.show-script { display: block; } .hide-script { display: none; }

Enable Javascript to enjoy full feature!

2 hours ago

SELLAS Life Sciences (SLS) Stock Soars 17% on Executive Contract Overhaul and M&A Buzz

SELLAS Life Sciences (SLS) stock climbed 17% Thursday after executive contract amendments sparked M&A speculation ahead of Phase 3 AML trial results.

The post SELLAS Life Sciences (SLS) Stock Soars 17% on Executive Contract Overhaul and M&A Buzz appeared first on Blockonomi.

Source: Blockonomi →

Related News